The Directorate General of Drug Administration announced the move on Sunday. The two Indian companies that supply the raw material – Ranitidine hydrochloride – are Saraca Laboratories Limited and Dr Reddy’s Laboratories, according to the DGDA. The drug authority has accordingly banned the production, sale and marketing of Ranitidine products made using the materials supplied by the Indian firms. But the ban is unlikely to have any impact on the treatment of patients, according to physicians. “But the cost of Ranitidine is slightly lower than others.”

Source: bd News24 November 14, 2019 08:41 UTC